Tech Company Financing Transactions

IsomAb Funding Round

IsomAb, based in Nottingham, secured $9.5 million in investment from Broadview Ventures, MEIF Proof of Concept & Early Stage Fund and Science Creates Ventures.

Transaction Overview

Company Name
Announced On
2/20/2024
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to carry out further studies in preparation for the start of clinical trials.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Biocity Nottingham Innovation Building Pennyfoot Street
Nottingham, NG1 1GF
UK
Phone
Undisclosed
Email Address
Overview
IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options. IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease.
Profile
IsomAb LinkedIn Company Profile
Social Media
IsomAb Company Twitter Account
Company News
IsomAb News
Facebook
IsomAb on Facebook
YouTube
IsomAb on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jackie Turnbull
  Jackie Turnbull LinkedIn Profile  Jackie Turnbull Twitter Account  Jackie Turnbull News  Jackie Turnbull on Facebook
Chief Financial Officer
Robin Pakenham
  Robin Pakenham LinkedIn Profile  Robin Pakenham Twitter Account  Robin Pakenham News  Robin Pakenham on Facebook
Chief Medical Officer
Stephen Harper
  Stephen Harper LinkedIn Profile  Stephen Harper Twitter Account  Stephen Harper News  Stephen Harper on Facebook
Chief Scientific Officer
David Bates
  David Bates LinkedIn Profile  David Bates Twitter Account  David Bates News  David Bates on Facebook
VP - Bus. Development
Chris Beattie
  Chris Beattie LinkedIn Profile  Chris Beattie Twitter Account  Chris Beattie News  Chris Beattie on Facebook
VP - Bus. Development
Kevin Brady
  Kevin Brady LinkedIn Profile  Kevin Brady Twitter Account  Kevin Brady News  Kevin Brady on Facebook
VP - Product Management
Kishor Modha
  Kishor Modha LinkedIn Profile  Kishor Modha Twitter Account  Kishor Modha News  Kishor Modha on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/20/2024: 9am.health venture capital transaction
Next: 2/20/2024: WeedOUT venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document all VC transactions involving tech companies. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary